ml 7 has been researched along with Hyperlipidemias in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, TB | 1 |
| Zhang, JJ | 1 |
| Liu, B | 1 |
| Liu, WQ | 1 |
| Wu, Y | 1 |
| Xiong, XM | 1 |
| Luo, XJ | 1 |
| Ma, QL | 1 |
| Peng, J | 1 |
1 other study available for ml 7 and Hyperlipidemias
| Article | Year |
|---|---|
Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia.
Topics: Animals; Azepines; Benzoxazoles; Cellular Senescence; Endothelial Progenitor Cells; Hyperlipidemias; | 2016 |